Category: A.M. Vitals: Six Health-Care IPOs Planned For This Week

MEwens
Also: Genzyme opens up to Sanofi; a jury rules against J&J; hormone picture gets more confusing.
Read more this great post here

MEwens
Also: Mass. merger talks; Hospira’s anesthetic decision; social networkers beware!
Read more this great post here

MEwens
Also: HHS announces fraud figures; Sanofi and Genzyme, still talking; an FDA panel weighs electroshock therapy.
Read more this great post here

MEwens
The move immediately sparked a dueling press release from Tenet, which reiterated its rejection of Community’s unsolicited acquisition bid.
Read more this great post here

Ron Winslow
Also: Oregon sues J&J; foreign health-insurers ponder the Chinese market; Endo’s in the hunt; how to treat ear infections.
Read more this great post here

MEwens
Also: premium-increase review in California; Tenet says 2011 outlook improves; Thermo Fisher Scientific seeks to sell two units.
Read more this great post here

MEwens
Also: health-law repeal vote pushed off; reports of J&J approach to Smith & Nephew; Prozac shows success in stroke patients.
Read more this great post here

MEwens
Also: alternatives to the individual mandate; Novartis finalizes terms of its Alcon deal; babies protected by pregnant mother’s flu shot.
Read more this great post here

MEwens
Also: unpopular health-care overhaul law provision and the tax-cut bill; health-care law ruling due today; secondhand smoke in apartment buildings.
Read more this great post here

MEwens
Also: “Mini-med” policyholders get letters explaining limited benefits; health-care M&A activity; Aetna’s Ronald Williams talks health-care overhaul.
Read more this great post here